Sentences with phrase «cancer center member»

Paul A. Godley, MD, PhD, MPP, is a UNC Lineberger Comprehensive Cancer Center member, Executive Associate Dean for Faculty Affairs and Professor in the Department of Hematology and Oncology at UNC - Chapel Hill School of Medicine.

Jason Akulian, MD, MPH Director, is a UNC Lineberger Comprehensive Cancer Center member, and Interventional Pulmonology Assistant Professor of Medicine Pulmonary and Critical Care Medicine at UNC - CH.

The study was led by UCLA's Jonsson Comprehensive Cancer Center member Dr. Joanne Weidhaas in collaboration with colleagues at the NRG Oncology RTOG.

The five - year study, led by UCLA Jonsson Comprehensive Cancer Center member Dr. Jianyu Rao, measured the ability of TSY - 1 to affect telomerase activity in cancer cells lines, including one known as HL - 60, as well as normal peripheral blood mononuclear and hematopoietic stem cells.

Meng and Nel also collaborated with Dr. Timothy Donahue, chief of gastrointestinal and pancreatic surgery and a Jonsson Comprehensive Cancer Center member, to demonstrate that treatment with the iRGD peptide can enhance tumor cell killing for patient - derived pancreatic cancers, growing subcutaneously in a mouse model.

«Even before the patient completes all of the MRIs, CT scans and other imaging procedures following diagnosis, we can have a recommendation for which drug and dosage to prescribe,» said Kareem Azab, PhD, an assistant professor of radiation oncology at the School of Medicine and the Siteman Cancer Center member who leads the research.

«What we found astonished us,» says study leader Andrew Feinberg, M.D., Bloomberg Distinguished Professor of Epigenetics at The Johns Hopkins University and a Johns Hopkins Kimmel Cancer Center member.

The recommendations aim to reduce unnecessary treatment for prostate cancer and potential long - term side effects from it, according to the University of North Carolina Lineberger Comprehensive Cancer Center member who first - authored the report.

Distinguished Professor in the UNC School of Medicine Department of Genetics and a UNC Lineberger Comprehensive Cancer Center member.

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

In a paper published by PLOS - ONE, UNC Lineberger Comprehensive Cancer Center members Nancy Klauber - DeMore, MD, professor of surgery, and Paul Dayton, PhD, professor of biomedical engineering, were able to visualize lesions created by angiosarcoma, a malignant cancer that develops on the walls of blood vessels.

A study led by UCLA's Drs. Robert Prins and Linda Liau, both UCLA Jonsson Comprehensive Cancer Center members, looked at the impact of a combined treatment using a chemotherapy drug called decitabine and genetically modified immune cells or T cell immunotherapy.

Research led by UNC Lineberger Comprehensive Cancer Center members Katherine Hoadley, PhD, research assistant professor in genetics and Chuck Perou, PhD, professor of genetics and pathology, was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2015, the Society's annual review of progress against cancer and emerging trends in the field.

The guests deliver a research seminar for Cancer Center members and are paired with a junior or mid-level clinical investigator to promote collaboration, networking and mentorship opportunities.

RFAs are distributed to cancer center members.

Mouse pathology services are free for Wistar Cancer Center members.

The GEMF generates mouse models for MD Anderson Cancer Center members and offers essential services for archiving important mouse models and rederiving novel models from outside sources.

Not exact matches

PICI (pronounced «pie - sea»), as it's called by its member scientists, is doing something unprecedented in academic medicine: combining and coordinating the efforts of six of the top cancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in ocancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in oCancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in others.

Oneida County Youth Bureau Director Kevin Green has recognized youth volunteers from The Center for Family Life and Recovery, Cornell Cooperative Extension, The Neighborhood Center, Thea Bowman House, John Bosco House, Utica Safe Schools / Underground Café and Dodge Pratt Northam Art Community all performed community service that included assisting in a bicycle giveaway for Utica children, making Christmas cards to send to veterans and service members, soliciting donations, collecting money and walking in Utica's version of America's Greatest Heart Run and Walk, the Walk to end Alzheimer's, Out of the Darkness Walk to Prevent Suicide, Making Strides to end Breast Cancer Walk, cleaning senior citizen's yards, preparing food and serving meals at local food pantries, youth mentoring and tutoring and other community activities.

Johnson says Roswell Park and cancer centers around the country will be pushing members of Congress to block those cuts - members like Clarence Republican Chris Collins, an investor in medical research and supporter of Roswell Park.

Armani, a faculty member in the new USC Michelson Center for Convergent Bioscience, indicated that in addition to the important role that quantum encryption could play in securing our healthcare information in the future, frequency combs are also being used to improve the detection of cancer biomarkers.

«This research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study in Nature.

The lead author is Darren Mays, PhD, MPH, assistant professor at Georgetown University Medical Center in Washington, D.C., and member of the Cancer Prevention and Control Program at the Georgetown Lombardi Comprehensive Cancer Center.

For those members of the NCI's Center for Cancer Research, the annual CCR - FYI Retreat may help fellows take that first proactive step.

«Although FDA approval is critically important for introducing a new screening test or algorithm, providers ultimately rely on guidance or guidelines to help them make the best decisions for their patients and want to understand advantages, disadvantages and unknowns associated with a new screening approach,» said Huh, who is a senior scientist for the UAB Comprehensive Cancer Center, Director of the UAB Division of Gynecologic Oncology, and is also a board member for both the American Society for Colposcopy and Cervical Pathology and the Society of Gynecologic Oncology.

«It's almost a childlike innocence — you ask questions that adults might never ask, because they have a background where the question is no longer appropriate,» says Harmit Singh Malik, an assistant member of the Seattle - based Fred Hutchinson Cancer Research Center's basic science division.

Greg Finak, a senior staff scientist at the Fred Hutchinson Cancer Research Center in Seattle, Washington, describes his role as a «mini-faculty» member.

«This is one way to focus our talents as synthetic chemists in a direction that can immediately help patients,» said Seth Herzon, a chemistry professor at Yale and member of the Yale Cancer Center.

«We have to hit cancer cells from more than one angle, and that's made it important to learn how to combine drugs that hit the right combination of pathways,» says Anne Le, M.D., H.D.R., assistant professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Ccancer cells from more than one angle, and that's made it important to learn how to combine drugs that hit the right combination of pathways,» says Anne Le, M.D., H.D.R., assistant professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer CCancer Center.

Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;

Young people with body mass indexes (BMIs) over 30 are more likely to experience aggressive malignancies, says author Nathan A. Berger, MD, Hanna - Payne Professor of Experimental Medicine; director of the Center for Science, Health and Society; member of the Case Comprehensive Cancer Center; and professor of medicine, biochemistry, oncology and genetics at Case Western Reserve University School of Medicine.

«There is currently no method that can predict treatment outcome of chemotherapy early on in treatment, so this is a major advance,» says Hielscher, co-leader of the study, who is also a member of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at NewYork - Presbyterian / Columbia University Irving Medical Center.

«This is a step forward in understanding pancreatic cancer's resistance to standard therapies,» said principal investigator Gregory Beatty, MD, PhD, an assistant professor of Hematology / Oncology at Penn and a member of Penn's Abramson Cancer Ccancer's resistance to standard therapies,» said principal investigator Gregory Beatty, MD, PhD, an assistant professor of Hematology / Oncology at Penn and a member of Penn's Abramson Cancer CCancer Center.

Liang Xu, Ph.D. member of the KU Cancer Center's Drug Discovery, Delivery and Experimental Therapeutics program and associate professor of molecular biosciences at KU, has discovered that targeting a cell - surface receptor called «CD44s» can block pancreatic tumor formation and recurrence after radiotherapy.

«Until now, the scientific community was looking for a genetic mutation to explain endometriosis,» said Bulun, a member of the Center for Genetic Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Nelson, a member of the Human Biology and the Public Health Sciences Divisions at Seattle's Fred Hutchinson Cancer Research Center, hopes to do just that.

We expected those with higher BMIs to benefit more from bariatric surgery,» says Schauer, also a UC Health physician and member of both the UC Cancer Institute and the Center for Clinical Effectiveness.

«There are still many questions left to answer but we now know that oxygen poor environments, like those often found in advanced human breast cancers serve as nurseries for the birth of cancer stem cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel Cancer Ccancer stem cells,» says Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine and a member of the Johns Hopkins Kimmel Cancer CCancer Center.

«Breast cancer stem cells pose a serious problem for therapy,» says lead study investigator Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine, director of the Vascular Biology Program at the Johns Hopkins Institute for Cell Engineering and a member of the Johns Hopkins Kimmel Cancer Ccancer stem cells pose a serious problem for therapy,» says lead study investigator Gregg Semenza, M.D., Ph.D., the C. Michael Armstrong Professor of Medicine, director of the Vascular Biology Program at the Johns Hopkins Institute for Cell Engineering and a member of the Johns Hopkins Kimmel Cancer CCancer Center.

García - Añoveros also is an investigator at Northwestern's Knowles Hearing Center and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Siziopikou also is a member of the Lurie Cancer Center.

She also is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Co-author Dr. Joshua Mendell, Professor of Molecular Biology at UT Southwestern and member of the UT Southwestern Harold C. Simmons Cancer Center, noted that his laboratory previously showed that miR - 34a can directly suppress the growth of cancer Cancer Center, noted that his laboratory previously showed that miR - 34a can directly suppress the growth of cancer cancer cells.

Other main contributors include Thomas Milner, professor of biomedical engineering in UT Austin's Cockrell School of Engineering and his lab members; Jialing Zhang, research associate at the Eberlin Lab at UT Austin who led the experimental work with other lab members; Anna Sorace, assistant professor at UT Austin's Dell Medical School; Chandandeep Nagi and Wendong Yu, professors of pathology at Baylor College of Medicine, and Jinsong Liu, professor of pathology at University of Texas MD Anderson Cancer Center.

Aifantis, the chair of the Department of Pathology at NYU Langone and a member of its Perlmutter Cancer Center, and an early career scientist at the Howard Hughes Medical Institute, says experiments in his laboratory had shown that leukemia - initiating cells concentrate in the bone marrow near CXCL12 - producing blood vessels.

«HPV vaccines could dramatically reduce the incidence of HPV - associated cancers, but uptake of these vaccines is far lower than for other routine childhood and teen immunizations,» said Kevin A. Henry, PhD, an assistant professor in the Department of Geography and Urban Studies at Temple University in Philadelphia and member of Fox Chase Cancer Center's Cancer Prevention and Control program.

Because the anti-retroviral drug maraviroc has already been approved by the U.S. Food and Drug Administration and has been shown safe for long term, oral use, it could be tested in clinical trials sooner rather than later, says Aleksander Popel, Ph.D., a professor in the Department of Biomedical Engineering at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center.

«We found that pemetrexed combined with cisplatin is less toxic, well tolerated, and should be developed for further treatment of cervical cancer,» said gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer Ccancer,» said gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer CCancer Center.

«This new finding may lead to the development of miR - 34a mimics as a new and better treatment for osteoporosis and cancers that metastasize to the bone,» said senior author Dr. Yihong Wan, Assistant Professor of Pharmacology and member of the UT Southwestern Harold C. Simmons Cancer Center.

an important step in gaining a better understanding of this difficult and particularly deadly disease,» said lead author Dr. Agnieszka Witkiewicz, Associate Professor of Pathology and a member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern.